Briefing Information for the April 4, 2017 Joint Meeting of the Nonprescription Drugs Advisory Committee (NDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance